Submissions are open for the upcoming issue.

Molecular Medicine Peer-reviewed scientific journal

Found: 6

ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 58–69

Polypragmasy in elderly and senile patients with chronic kidney disease: START/STOP criteria in elderly and senile patients taking DOAC

Introduction. Thanks to the achievements of modern medicine, it was possible to significantly increase the life expectancy of the population. Molecular mechanisms of aging include telomere shortening, DNA damage accumulation, mitochondrial dysfunction, leading…

10.29296/24999490-2025-05-07Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2018

THE PREVALENCE OF CYP2C19*2, *3 POLYMORPHISMS AMONG RUSSIANS AND YAKUTS WITH PEPTIC ULCER DISEASE, LIVING IN SAKHA REPUBLIC (YAKUTIA)

Introduction. Proton pump inhibitors (PPI) are widely spread as antisecretory drugs for a treatment of acid diseases, such as the gastric ulcer. Most of the proton pump inhibitors are inactivated in the liver by cytochromes P450 2C19 (CYP2C19) to the form of i…

10.29296/24999490-2018-04-06Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2018

THE CYP2C19*2, CYP2C19*3 POLYMORPHISMS ASSOCIATED WITH THE RESISTANCE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SINDROME IN THE YAKUT AND RUSSIAN ETHNIC GROUPS

ntroduction. The aim of this study was to determine the prevalence rate of CYP2C19 alleles, associated with the risk of the resistance to clopidogrel and the development of thrombotic complications in patients with acute coronary syndrome (ACS) from Russian an…

10.29296/24999490-2018-02-08Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2017

CLINICAL SIGNIFICANCE OF GENE CYP2C19 POLYMORPHISM IN STEMI PATIENTS (DATA FROM THE KEMEROVO REGISTRY OF THE ACUTE CORONARY SYNDROME)

Aim is to evaluate distribution and clinical significance of gene CYP2C19 polymorfism in ST-segment elevation myocardial infarction (STEMI) patients. Materials and methods. A total of 159 patients were encluded in this study. All of them underwent primary PCI.…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015

PREVALENCE OF CYP2C19 GENETIC POLYMORPHISMS IN RUSSIAN PATIENTS WITH PEPTIC ULCERS TREATED WITH PROTON PUMP INHIBITORS

Introduction. Cytochrome P-450 2C19 is the main isoenzyme responsible for the metabolism of proton pump inhibitors, the main group of drugs for treating stomach and duodenal ulcer. There are genetic differences that affect the activity of this enzyme: there ar…

Details ↗

Article search and quick navigation

Navigation